Skip to main content
OPZELURA 15 mg/g cream by Incyte Corporation
OPZELURA, 15 mg/g, cream Drug class: Janus Kinase Inhibitor; Kinase Inhibitor. Available on prescription only. Listed by Incyte Corporation.
Prescription only

OPZELURA

ruxolitinib

Listed by Incyte Corporation

Strength
15 mg/g
Form
Cream
Route
Topical
Class
Janus Kinase Inhibitor; Kinase Inhibitor

What it contains

  • Ruxolitinib Phosphate 15 mg/g

FDA record

Dosage form Cream
Route Topical
Drug class Janus Kinase Inhibitor; Kinase Inhibitor
Approval route NDA — original brand approval
NDC code 50881-007
FDA application NDA215309
RxNorm concept 2570752
Package sizes listed 4
Marketed since September 2021

Other products containing Ruxolitinib

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

JAKAFI

ruxolitinib

Strength
10 mg/1
Form
Tablet
Class
Janus Kinase Inhibitor; Kinase Inhibitor
Rx only

Incyte Corporation

$483.00 We supply Rutinib cream 1.5% 1 tube 30 g (different strength or form) View product

JAKAFI

ruxolitinib

Strength
25 mg/1
Form
Tablet
Class
Janus Kinase Inhibitor; Kinase Inhibitor
Rx only

Incyte Corporation

$483.00 We supply Rutinib cream 1.5% 1 tube 30 g (different strength or form) View product

JAKAFI

ruxolitinib

Strength
15 mg/1
Form
Tablet
Class
Janus Kinase Inhibitor; Kinase Inhibitor
Rx only

Incyte Corporation

$483.00 We supply Rutinib cream 1.5% 1 tube 30 g (different strength or form) View product

JAKAFI

ruxolitinib

Strength
5 mg/1
Form
Tablet
Class
Janus Kinase Inhibitor; Kinase Inhibitor
Rx only

Incyte Corporation

$483.00 We supply Rutinib cream 1.5% 1 tube 30 g (different strength or form) View product

JAKAFI

ruxolitinib

Strength
20 mg/1
Form
Tablet
Class
Janus Kinase Inhibitor; Kinase Inhibitor
Rx only

Incyte Corporation

$483.00 We supply Rutinib cream 1.5% 1 tube 30 g (different strength or form) View product

JAKAFI XR

ruxolitinib

Strength
33 mg/1
Form
Tablet, Extended Release
Class
Janus Kinase Inhibitor; Kinase Inhibitor
Rx only

Incyte Corporation

$483.00 We supply Rutinib cream 1.5% 1 tube 30 g (different strength or form) View product

JAKAFI XR

ruxolitinib

Strength
11 mg/1
Form
Tablet, Extended Release
Class
Janus Kinase Inhibitor; Kinase Inhibitor
Rx only

Incyte Corporation

$483.00 We supply Rutinib cream 1.5% 1 tube 30 g (different strength or form) View product

JAKAFI XR

ruxolitinib

Strength
55 mg/1
Form
Tablet, Extended Release
Class
Janus Kinase Inhibitor; Kinase Inhibitor
Rx only

Incyte Corporation

$483.00 We supply Rutinib cream 1.5% 1 tube 30 g (different strength or form) View product

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.